@nantakie:

เจ้าเนื้อ 🥩

Open In TikTok:

Region: TH

Sunday 29 December 2024 12:19:27 GMT

24571

168

4

0

Music

Download

No Watermark .mp4 (0.71MB) No Watermark(HD) .mp4 (3.06MB) Watermark .mp4 (0.82MB) Music .mp3

Comments

Sompong Phogranad :

🥰

2025-01-15 06:09:43

0

To see more videos from user @nantakie, please go to the Tikwm homepage.

Other Videos

#duet with @1d6zion #foodopinion #myopinion #foodreview #foodreaction #foodreactions #foodcomentary #rant #rants #ranting

#duet with @1d6zion #foodopinion #myopinion #foodreview #foodreaction #foodreactions #foodcomentary #rant #rants #ranting

cheating isnt just physical 😭😭

cheating isnt just physical 😭😭

#CapCut

I want to share a study being presented as a poster at #SABCS24 by Dr. Savannah Roy and her team (Abstract Number: SESS-2438) looking at the incidence of major adverse cardiovascular events (MACE) (heart attack, stroke arrhythmia or heart failure) in postmenopausal and premenopausal women with hormone receptor-positive breast cancer/HER2 negative undergoing endocrine therapy. Here are the key points that I go into the video: 📌 The association of cardiovascular events with aromatase inhibitors has been controversial. 📌 This analysis looked at over 26,000 postmenopausal women with HR+/HER2- breast cancer diagnosed at age >65 and premenopausal women diagnosed at age <45 and experiencing premature menopause or undergoing ovarian function suppression. 📌 Patients with HER2-positive breast cancer were excluded to avoid the additional confounder of potential cardiotoxicity from HER2 targeted agents. ⁉️ What did they find? ⭐️ In postmenopausal women with HR+/HER2- breast cancer, AI treatment was not associated with increased risk of cardiac outcomes compared to tamoxifen. ⭐️ There was a lower proportion of cardiac events in women with premature menopausal or those undergoing OFS (3.54%) compared to postmenopausal women (28%). ⭐️ The follow-up was a little under 5 years so we absolutely need longer follow-up but this is very helpful information especially in the short-term. ⁉️ Let me know your questions on this study or on cardiac toxicity and breast cancer medications in general and will see what I can answer! #breastcancer #cardiac #heartdisease

I want to share a study being presented as a poster at #SABCS24 by Dr. Savannah Roy and her team (Abstract Number: SESS-2438) looking at the incidence of major adverse cardiovascular events (MACE) (heart attack, stroke arrhythmia or heart failure) in postmenopausal and premenopausal women with hormone receptor-positive breast cancer/HER2 negative undergoing endocrine therapy. Here are the key points that I go into the video: 📌 The association of cardiovascular events with aromatase inhibitors has been controversial. 📌 This analysis looked at over 26,000 postmenopausal women with HR+/HER2- breast cancer diagnosed at age >65 and premenopausal women diagnosed at age <45 and experiencing premature menopause or undergoing ovarian function suppression. 📌 Patients with HER2-positive breast cancer were excluded to avoid the additional confounder of potential cardiotoxicity from HER2 targeted agents. ⁉️ What did they find? ⭐️ In postmenopausal women with HR+/HER2- breast cancer, AI treatment was not associated with increased risk of cardiac outcomes compared to tamoxifen. ⭐️ There was a lower proportion of cardiac events in women with premature menopausal or those undergoing OFS (3.54%) compared to postmenopausal women (28%). ⭐️ The follow-up was a little under 5 years so we absolutely need longer follow-up but this is very helpful information especially in the short-term. ⁉️ Let me know your questions on this study or on cardiac toxicity and breast cancer medications in general and will see what I can answer! #breastcancer #cardiac #heartdisease

#jessyb208 #odogwuparanran #loveineveryword #viraltiktokvideo #fypシ゚ #fypppppppppppppp #achalugo #goviral #tren

#jessyb208 #odogwuparanran #loveineveryword #viraltiktokvideo #fypシ゚ #fypppppppppppppp #achalugo #goviral #tren

About

Robot

Legal

Privacy Policy